Teijin-lead_cmp_5 [Ligand Id: 785] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL337246
  • CCR2/C-C chemokine receptor type 2 in Human [ChEMBL: CHEMBL4015] [GtoPdb: 59] [UniProtKB: P41597]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
CCR2/C-C chemokine receptor type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4015] [GtoPdb: 59] [UniProtKB: P41597]
ChEMBL Binding affinity of compound (10 uM) towards T292A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells B 5.11 pKi 7762.47 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Binding affinity of compound (10 uM) towards H121A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells B 5.59 pKi 2570.4 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Binding affinity of compound (10 uM) towards Y1210A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells B 5.74 pKi 1819.7 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Binding affinity of compound (10 uM) towards D284A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells B 6.14 pKi 724.44 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Binding affinity of compound (10 uM) towards H121F receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells B 6.18 pKi 660.69 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Binding affinity of compound (10 uM) towards WT receptor variant (mutant C-C chemokine receptor type 2) using radioligand [125I]MCP-1 in HEK 293 cells B 6.47 pKi 338.84 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Binding affinity of compound (10 uM) towards Y49F receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells B 6.5 pKi 316.23 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Binding affinity of compound (10 uM) towards Q288A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells B 6.5 pKi 316.23 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
GtoPdb - - 6.5 pKi - - - J Med Chem (2003) 46: 4070-86 [PMID:12954060]
ChEMBL Binding displacement of [125I]MCP-1 (0.14 nM) was measured on CHO cell membranes expressing human CCR2 (C-C chemokine receptor type 2) B 6.54 pKi 288.4 nM Ki J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Displacement of [125I]MCP1 from human CCR2B receptor expressed in HEK293-EBNA cells B 6.21 pIC50 610 nM IC50 Bioorg Med Chem Lett (2010) 20: 2099-2102 [PMID:20223662]
ChEMBL Antagonist activity at human CCR2B receptor expressed in HEK293 cells assessed as inhibition of MCP1-induced increase in intracellular calcium level F 6.52 pIC50 300 nM IC50 Bioorg Med Chem Lett (2010) 20: 2099-2102 [PMID:20223662]
ChEMBL Antagonist activity at CCR2 in human THP1 cells assessed as inhibition of MCP1-induced chemotaxis after 1 hr by crystal violet staining F 7.15 pIC50 70 nM IC50 Bioorg Med Chem Lett (2010) 20: 2099-2102 [PMID:20223662]
ChEMBL Displacement of [125I]MCP1 from human CCR2b in THP1 cells B 7.27 pIC50 54 nM IC50 Bioorg Med Chem Lett (2008) 18: 1869-1873 [PMID:18313297]
ChEMBL Inhibitory activity against C-C chemokine receptor type 2 (antagonist activity) F 7.27 pIC50 54 nM IC50 J Med Chem (2003) 46: 4070-4086 [PMID:12954060]
ChEMBL Displacement of [125]MCP1 from CCR2 in human PBMCs B 7.77 pIC50 17 nM IC50 Bioorg Med Chem Lett (2007) 17: 5455-5461 [PMID:17720492]
ChEMBL Antagonist activity at human CCR2 in THP1 cells assessed as inhibition of MCP1-induced chemotaxis F 7.8 pIC50 16 nM IC50 Bioorg Med Chem Lett (2008) 18: 1869-1873 [PMID:18313297]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]